Argentina ANMAT proposes guidelines for decentralized clinical trials

Dct Decentralised Clinical Trial
Argentina ANMAT guide outlines the requirements for decentralized elements in clinical pharmacology studies, including roles and responsibilities for the sponsor and investigators, Informed Consent, delivery of investigational products, study procedures, supportive software, and storage of clinical data.
The regulatory requirements of ANMAT…

Sorry, this premium content is for RegASK clients only.

Want to access the whole content of the alert or browse all the news? 


Have a
regulatory affairs

Regulatory Affair Icon